Chargement en cours...
CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors reduce the risk of cardiovascular events and all-cause mortality in patients at high risk of cardiovascular disease (CVD). Due to high costs and unknown long-term adverse effects, critical evaluation of patients considered for PCSK9 in...
Enregistré dans:
| Publié dans: | Diseases |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6023332/ https://ncbi.nlm.nih.gov/pubmed/29861477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases6020045 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|